These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7685612)

  • 1. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of triciribine is necessary for activity against HIV type 1.
    Ptak RG; Borysko KZ; Porcari AR; Buthod JL; Holland LE; Shipman C; Townsend LB; Drach JC
    AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1315-22. PubMed ID: 9788672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral activity of 2-substituted analogs of triciribine.
    Porcari AR; Ptak RG; Borysko KZ; Breitenbach JM; Drach JC; Townsend LB
    Nucleosides Nucleotides Nucleic Acids; 2003 Dec; 22(12):2171-93. PubMed ID: 14714765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nef.
    Ptak RG; Gentry BG; Hartman TL; Watson KM; Osterling MC; Buckheit RW; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1512-9. PubMed ID: 20086149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-N-Acyltriciribine analogues: structure-activity relationship between acyl carbon chain length and activity against HIV-1.
    Porcari AR; Ptak RG; Borysko KZ; Breitenbach JM; Drach JC; Townsend LB
    J Med Chem; 2000 Jun; 43(12):2457-63. PubMed ID: 10882373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxy sugar analogues of triciribine: correlation of antiviral and antiproliferative activity with intracellular phosphorylation.
    Porcari AR; Ptak RG; Borysko KZ; Breitenbach JM; Vittori S; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 2000 Jun; 43(12):2438-48. PubMed ID: 10882371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.
    Balzarini J; Karlsson A; Pérez-Pérez MJ; Camarasa MJ; De Clercq E
    Virology; 1993 Oct; 196(2):576-85. PubMed ID: 7690501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents.
    Buckheit RW; Germany-Decker J; Hollingshead MG; Allen LB; Shannon WM; Janssen PA; Chirigos MA
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1097-106. PubMed ID: 7508723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
    J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates.
    White EL; Buckheit RW; Ross LJ; Germany JM; Andries K; Pauwels R; Janssen PA; Shannon WM; Chirigos MA
    Antiviral Res; 1991 Oct; 16(3):257-66. PubMed ID: 1725247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine.
    Migawa MT; Drach JC; Townsend LB
    J Med Chem; 2005 Jun; 48(11):3840-51. PubMed ID: 15916436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-human immunodeficiency virus (HIV) activities of halogenated gomisin J derivatives, new nonnucleoside inhibitors of HIV type 1 reverse transcriptase.
    Fujihashi T; Hara H; Sakata T; Mori K; Higuchi H; Tanaka A; Kaji H; Kaji A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2000-7. PubMed ID: 8540706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication.
    Pauwels R; Andries K; Debyser Z; Kukla M; Schols D; Desmyter J; De Clercq E; Janssen PA
    Biochem Soc Trans; 1992 May; 20(2):509-12. PubMed ID: 1383063
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors.
    Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP
    J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.
    Pauwels R; Andries K; Debyser Z; Van Daele P; Schols D; Stoffels P; De Vreese K; Woestenborghs R; Vandamme AM; Janssen CG
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1711-5. PubMed ID: 7680476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single conservative amino acid substitution in the reverse transcriptase of human immunodeficiency virus-1 confers resistance to (+)-(5S)-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5, 1- jk][1,4]benzodiazepin-2(1H)-thione (TIBO R82150).
    Mellors JW; Im GJ; Tramontano E; Winkler SR; Medina DJ; Dutschman GE; Bazmi HZ; Piras G; Gonzalez CJ; Cheng YC
    Mol Pharmacol; 1993 Jan; 43(1):11-6. PubMed ID: 7678690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.
    Debyser Z; Pauwels R; Andries K; Desmyter J; Kukla M; Janssen PA; De Clercq E
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1451-5. PubMed ID: 1705038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of LC/MS/MS method for Triciribine and its monophosphate metabolite in plasma and RBC: Application to mice pharmacokinetic studies.
    Narayanan S; Shandil RK; Ahuja VK; Shanmugam SS; Mahesh K U H; Ramesh N; Surendran N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1174():122714. PubMed ID: 33962189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.